ArticleClinical and experimental nephrology2025
Association of stress hyperglycemia ratio with hospital mortality and acute kidney injury in patients with transfusion.
Article in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integration of stress hyperglycemia ratio and c-reactive protein level improves postoperative acute kidney injury risk stratification after noncardiac surgery: A nested case-control study.Pakistan journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients in intensive care units (ICUs) commonly experience stress hyperglycemia, which is linked with poor cardiovascular outcomes and high hospital mortality. The stress hyperglycemia ratio (SHR) may serve as a critical risk factor for acute kidney injury (AKI) in specific individuals. Nevertheless, the link between SHR and hospital mortality and AKI in transfused patients is unclarified.
methodsParticipants were non-consecutively sourced from the MIMIC-IV database and allocated into quartiles based on SHR. Hospital mortality and AKI incidence were the endpoints. The association of SHR with hospital mortality and AKI was examined through restricted cubic splines and Cox models. Endpoint differences across quartiles were estimated using the Kaplan-Meier method.
results1381 patients were enrolled, with 59% of males. AKI incidence was 81.0% and in-hospital death was 9.8%. Cox analyses revealed a notable link of SHR with hospital death in critically ill transfused patients, while the correlation with AKI was comparatively weak. However, it also showed a notable link of SHR with hospital death and AKI risk of non-diabetes. Restricted cubic spline models uncovered a linear connection between SHR and AKI risk and a nonlinear connection between SHR and in-hospital death. After adjustment of variables in Model 3, it showed a nonlinear relationship of SHR with in-hospital death and AKI risk of non-diabetes. Furthermore, in-hospital survival considerably varied in transfused patients with different SHR levels.
conclusionsSHR independently predicts hospital mortality in critically ill transfused patients. Among non-diabetes, SHR is significantly associated with hospital mortality and AKI risk. However, larger prospective studies are warranted to check the causality.
Indexed as
Identifiers
40684008What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.